» Articles » PMID: 20451516

Activation of Fibroblasts in Cancer Stroma

Overview
Journal Exp Cell Res
Specialty Cell Biology
Date 2010 May 11
PMID 20451516
Citations 239
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor microenvironment has emerged as an important target for cancer therapy. In particular, cancer-associated fibroblasts (CAF) seem to regulate many aspects of tumorigenesis. CAFs secrete a variety of soluble factors that act in a paracrine manner and thus affect not only cancer cells, but also other cell types present in the tumor stroma. Acting on cancer cells, CAFs promote tumor growth and invasion. They also enhance angiogenesis by secreting factors that activate endothelial cells and pericytes. Tumor immunity is mediated via cytokines secreted by immune cells and CAFs. Both immune cells and CAFs can exert tumor-suppressing and -promoting effects. CAFs, and the factors they produce, are attractive targets for cancer therapy, and they have proven to be useful as prognostic markers. In this review we focus mainly on carcinomas and discuss the recent findings regarding the role of activated fibroblasts in driving tumor progression.

Citing Articles

Decoupling chemical and mechanical signaling in colorectal cancer cell migration.

Tetrick M, Emon M, Doha U, Marcellus M, Symanski J, Ramanathan V Sci Rep. 2025; 15(1):4952.

PMID: 39929899 PMC: 11811049. DOI: 10.1038/s41598-025-89152-4.


Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets.

Lv K, He T Mol Biomed. 2024; 5(1):70.

PMID: 39680287 PMC: 11649616. DOI: 10.1186/s43556-024-00233-8.


Mesenchymal stromal cells as cancer promoters.

Antoon R, Overdevest N, Saleh A, Keating A Oncogene. 2024; 43(49):3545-3555.

PMID: 39414984 PMC: 11602730. DOI: 10.1038/s41388-024-03183-1.


Correlating Ultrastructural Changes in the Invasion Area of Colorectal Cancer with CT and MRI Imaging.

Urbaniec-Stompor J, Michalak M, Godlewski J Int J Mol Sci. 2024; 25(18).

PMID: 39337393 PMC: 11432200. DOI: 10.3390/ijms25189905.


TALEN-edited allogeneic inducible dual CAR T cells enable effective targeting of solid tumors while mitigating off-tumor toxicity.

Dharani S, Cho H, Fernandez J, Juillerat A, Valton J, Duchateau P Mol Ther. 2024; 32(11):3915-3931.

PMID: 39169622 PMC: 11573618. DOI: 10.1016/j.ymthe.2024.08.018.